Relypsa, Inc. Adds Key Leadership Positions to Support Late-Stage Development and Pre-Launch Commercial Activities
5/19/2011 10:28:00 AM
SANTA CLARA, Calif.--(BUSINESS WIRE)--Relypsa, Inc. today announced the appointments of Klaus Veitinger, M.D., Ph.D., to the new position of Vice Chairman, and James A. Johnson to the new position of Senior Vice President and Chief Financial Officer. Dr. Veitinger brings to the company significant commercial and general business management expertise based on his successful track record in running pharmaceutical companies and now, on the private equity side, where he is taking a hands-on approach at the board level. Mr. Johnson is a veteran financial executive who brings to the company more than 30 years of financial and operational management experience, including over 20 years in the biotechnology industry.